期刊文献+

芸香宁碱及其衍生物的合成研究进展

Review on Synthesis of Graveolinine and Its Derivatives
下载PDF
导出
摘要 芸香宁碱属于2-苯基喹啉类,是从华南地区芸香科植物中提取出来的生物碱,具有广泛的生理活性。其合成分为多步法和一步法。前者原料价格低廉,反应条件温和,但是周期较长,原子利用率不高;一步法具有路线短,原子利用率高的优点,但原料价格昂贵,不易获得,反应收率低。目前中间体法更加经济,更容易衍生化,适用于实验室。但随着合成方法学的发展和高效催化剂的发现,一步法也可使用廉价易得的原料,具有更广阔的发展空间。 Graveolinine belongs to the 2-phenyl quinolone compounds, which is isolated from Ruta graveolens L. in the south of China. It has showed comprehensive pharmacological activities. The main synthesis methods of graveolinine derivatives could be divided into the multi-steps and one-step methods. The multi-steps method has the advantages of low material price and mild reaction conditions. Hhowever, the preparation scheme is long and the atomic utilization rate is not high. The one-step method has the advantages of short route and high atomic utilization rate, but the materials are expensive or difficult to obtain, and the yield is low. At present, the multi-steps method is more economy, easier to derivatize, and suitable for using in laboratory. However, with the development of synthetic methodologies and the discovery of high-efficiency catalysts, the one-step method can also use cheap and commercial available materials, and it will have a great potential for future development.
作者 罗稳 赵永梅 吕剑伍 王婷 LUO Wen;ZHAO Yong-mei;LV Jian-wu;WANG Ting(Key Laboratory of Natural Medicine and Immuno-Engineering, Henan University, Henan Kaifeng 475004;Pharmaceutical Engineering Department, Henan Vocational College of Applied Technology, Henan Kaifeng 475004, China)
出处 《广州化工》 CAS 2019年第13期19-20,32,共3页 GuangZhou Chemical Industry
基金 河南省高等学校青年骨干教师培养计划(No.2016GGJS-030) 国家自然科学基金项目(No.U1704176)
关键词 2-苯基喹啉 芸香宁碱 合成 研究进展 graveolinine 2-phenyl quinoline synthesis review
  • 相关文献

参考文献1

二级参考文献20

  • 1陈蓉,王佑华,聂颖颖,王鹂,刘学法.鸡胚绒毛尿囊膜技术应用体会[J].安徽医药,2005,9(12):950-950. 被引量:2
  • 2Folkman J. Angiogenesis in cancer,vascular,rheumatoid and other disease [ J ]. Nat Med, 1995,1 ( 1 ) :27 - 31.
  • 3Squadrito ML, Palma MD, Michele DP. Macrophage regulation of tumor angiogenesis: Implication for cancer therapy [ J]. Mol As- pects Med,2011,32(2) :123 - 145.
  • 4Aragon - Ching JB, Madan RA, Dahut WL. Angiagenesis inhibition in prostate cancer:current uses and future premises [ J ]. J Oncol, 2010,2010:361836.
  • 5Qin L, Bromberg- White JL, Qian CN. Opportunities and challen- ges in tumor angiogenesis research:back and forth between benc- hand bed [J]. Adv Cancer Res,2012,113:191 -239.
  • 6Linkous AG,Yazlovitskaya EM. Novel therapeutic approaches for tar- geting tumor Angiogenesis [ J ]. Anticancer Res ,2012 ,32 ( 1 ) : 1 - 12.
  • 7Lin J, Yah XJ, Chen HM. Fascaplysin, a selective CDK4 inhibitor, exhibit anti -angiogenic activity in vitro and in vivo [ J ]. Cancer Chemother Phmarmacol,2007,59(4) :439 -445.
  • 8Zhang X, Lawler J. Thrombospondin - based antiangiogenic therapy [ J ]. Mirevasc Res,2007,74 (2/3) :90 - 99.
  • 9Zhong H, Bowen JP. Antiangiogenesis drug design : multiple path- ways targeting tumor Vascula ture [J]. Curt Med Chem,2006,13 (8) :849 -862.
  • 10Oliva A, Meepagala KM, Wedge DE, et al. Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid [J]. J Agric Food Chem,2003,51 (4) :890-896.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部